期刊文献+

2013年心力衰竭研究热点 被引量:3

Progress of heart failure in 2013
原文传递
导出
摘要 2013年,心力衰竭(心衰)的研究热点集中在急性心衰、射血分数代偿的心衰及心衰的装置治疗3大领域。本文主要介绍ROSE,RELAX-AHF,ATOMIC-AHF,ASTRONAUT,BCIS-1,PROTECT-Ⅱ,TOPCAT,RELAX,ADVANCE,Echo-CRT,RAFT,BLOCK-HF,IN-TIME及RED-HF等研究成果,并就相关热点问题进行讨论。 In 2013 there were new clinical trials that focus on acute heart failure (HF), heart failure with preserved ejection fraction (EF), and device therapy in HF. This article introduced ROSE, RELAX-AHF, ATOMIC-AHF, ASTRONAUT, BCIS-1, PROTECT-H, TOPCAT, RELAX, ADVANCE, Echo-CRT, RAFT, BLOCK-HF, IN-TIME, and RED-HF trails, and discussed related hot issues.
作者 卢永昕
出处 《临床心血管病杂志》 CAS CSCD 北大核心 2014年第4期275-277,共3页 Journal of Clinical Cardiology
关键词 心力衰竭 奈西利肽 重组人松弛素 心脏再同步化治疗 heart failure nesiritide recombinant human relaxin cardiac resynchronizatian therapy
  • 相关文献

参考文献7

  • 1GIVERTZ M M. TEERLINKJR. ALBERT N M. et al. Acute decompensated heart failure, updated on new and emerging evidence and directions for future research[J].J Cardiac Fail.2013.19,371-389.
  • 2EZEKOWITZJ A. Novel pharmacologic therapies in development for acute decompensated heart failure[J]. Curr Cardiol Rep.2013.15,329-329.
  • 3PERERA D. STABLES R. CLAYTON To et al. Long-Term mortality data from the balloon pump-assisted coronary intervention study (BCIS-1), A randomized controlled tials of elective balloon counterpulsation during high-risk percutaneous coronary intervention[J]. Circulation. 2013 .127,207- 212.
  • 4LIU W. MUKKU V K. GILANI S. et al. Percutaneous Hemodynamic Support (Impella) in Patients with Advanced Heart Failure and/or Cardiogenic Shock not Eligible to PROTECT II Trial[J]. IntJ Angiol , 2013.22,207 - 212.
  • 5DESAI A S. LEWIS E F. LI R. et al. Rationale and design -of the treatment of preserved cardiac function heart failure with an aldosterone antagonist trial[J]. Am HeartJ .2011,162,966-972.
  • 6WHELLAN DJ. GOODLIN SJ. DICKINSON M G. et al. End-of-life care in patients with heart failure[J].J Cardiac Fail. 2014.20,121 -134.
  • 7TANG A S. WELLS G A. TALAJIC M. et al. Cardiac resynchronization therapy for mild-to-moderate heart failure[J]. N EnglJ Med , 2010.363, 2385 - 2395 .

同被引文献36

  • 1侯明晓,柳云恩,张玉彪,施琳.急性心脏衰竭治疗研究进展[J].创伤与急危重病医学,2013,1(1):9-12. 被引量:3
  • 2Goonewardena SN, Gemignani A, Ronan A, et al. Comparison of hand-carried ultrasound assessment of the inferior vena cava and N-terminal pro-brain natriuretic peptide for predicting readmission after hospitalization for acute decompenshted heart failure [J]. JACC, 2008,1 (5) : 595-601.
  • 3Turley AJ,Raja SG, Salhiyyah K, et al. Does cardiac resynchroni- zation therapy improve survival and quality of life in patients with end-stage heart failure? [J]. Interact Cardiovase Thorae Surg. 2008,7(6) : 1141-1146.
  • 4Raveen Kandan S,Augustine D,Easaw J. Are we using BNP wise- ly ? Audit of the utility of natriuretic peptide testing (NT-Prob- np) in banes, Wiltshire and somerset for patients with suspected heart failure [J]. Heart, 2014,100(Suppl 3):24-25.
  • 5Matthias P, Peter B, Hans R, et al. BNP-Guided vs Symptom-Guided Heart Failure [J]. Therapy, 2009,301 (4) :383- 392.
  • 6Flint KM,Allern LA, Pharm M, et al. B-Type natriuretic peptide predicts 30-day readmission for heart failure but not readmission for other causes[J]. J Am Heart Assoc. 2014, 3 (3):Pii. E000806.
  • 7Dahle DO,Jenssen T, H oldaas H, et al. Uric acid has a J-shaped association with cardiovascular and all-cause mortality in kidney transplant recipients [J]. Clin Transplant. 2014,28(1):134-140.
  • 8Amaral FA, Costa VV, Tavares LD, et al. NLRP3 inflammasome mediated neutrophil recruitment and hypernoeiception depend on leukotriene B (4) in a murine model of gout [J]. Arthritis Rheum,2012,64(2) :474-484.
  • 9Lin H, Zhou Y, Xu G. Predictors for eardic resynchronization therapy response [J]. Int Heart J. 2014,55(3) :256-263.
  • 10Pitt B. Multiple rennin-angiotensin-aldosterone-blocking agents in hear failure:how much is too much? [J]. Curt Heart Fail Rep, 2009,6(2) : 112-116.

引证文献3

二级引证文献63

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部